- Home
- POCI vs COEP Comparison
POCI vs COEP Comparison
Compare POCI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- COEP
- Stock Information
- Founded
- POCI 1982
- COEP 2017
- Country
- POCI United States
- COEP United States
- Employees
- POCI N/A
- COEP N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POCI Health Care
- COEP Health Care
- Exchange
- POCI Nasdaq
- COEP Nasdaq
- Market Cap
- POCI 35.0M
- COEP 32.4M
- IPO Year
- POCI N/A
- COEP N/A
- Fundamental
- Price
- POCI $4.69
- COEP $10.45
- Analyst Decision
- POCI
- COEP
- Analyst Count
- POCI 0
- COEP 0
- Target Price
- POCI N/A
- COEP N/A
- AVG Volume (30 Days)
- POCI 14.4K
- COEP 60.3K
- Earning Date
- POCI 02-13-2025
- COEP 05-09-2025
- Dividend Yield
- POCI N/A
- COEP N/A
- EPS Growth
- POCI N/A
- COEP N/A
- EPS
- POCI N/A
- COEP N/A
- Revenue
- POCI $18,682,766.00
- COEP N/A
- Revenue This Year
- POCI N/A
- COEP N/A
- Revenue Next Year
- POCI N/A
- COEP N/A
- P/E Ratio
- POCI N/A
- COEP N/A
- Revenue Growth
- POCI N/A
- COEP N/A
- 52 Week Low
- POCI $3.47
- COEP $2.31
- 52 Week High
- POCI $6.90
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- POCI 51.06
- COEP 48.25
- Support Level
- POCI $4.42
- COEP $10.00
- Resistance Level
- POCI $5.04
- COEP $11.75
- Average True Range (ATR)
- POCI 0.37
- COEP 1.07
- MACD
- POCI 0.03
- COEP -0.12
- Stochastic Oscillator
- POCI 66.35
- COEP 48.22
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.